{
    "2020-10-12": [
        [
            {
                "time": "",
                "original_text": "一年间估值差2亿:华熙生物2.9亿收购亏损标的 相关资产疑问待解 投资失误",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "收购",
                        "亏损标的",
                        "投资失误"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "这可能是中国最混乱的暴利生意",
                "features": {
                    "keywords": [
                        "暴利生意",
                        "混乱"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}